GRGRX
Price
$47.02
Change
+$0.19 (+0.41%)
Updated
Jun 12 closing price
Net Assets
400.93M
RMFEX
Price
$58.31
Change
+$0.33 (+0.57%)
Updated
Jun 12 closing price
Net Assets
105.64B
Interact to see
Advertisement

GRGRX vs RMFEX

Header iconGRGRX vs RMFEX Comparison
Open Charts GRGRX vs RMFEXBanner chart's image
Goldman Sachs Equity Income R
Price$47.02
Change+$0.19 (+0.41%)
VolumeN/A
Net Assets400.93M
American Funds American Mutual R4
Price$58.31
Change+$0.33 (+0.57%)
VolumeN/A
Net Assets105.64B
GRGRX vs RMFEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GRGRX vs. RMFEX commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRGRX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 106B vs. GRGRX (401M). RMFEX pays higher dividends than GRGRX: RMFEX (1.58) vs GRGRX (1.04). GRGRX was incepted earlier than RMFEX: GRGRX (18 years) vs RMFEX (23 years). GRGRX (1.45) is less costly to investors than RMFEX (0.62). GRGRX (31.00) and RMFEX (31.00) have comparable annual turnover. GRGRX has a lower initial minimum investment than RMFEX: GRGRX (0) vs RMFEX (250). RMFEX annual gain was more profitable for investors over the last year : 9.82 vs. GRGRX (4.08). RMFEX return over 5 years is better than : 63.58 vs. GRGRX (43.34).
GRGRXRMFEXGRGRX / RMFEX
Total Expense Ratio1.250.62202%
Annual Report Gross Expense Ratio1.450.62234%
Fund Existence18 years23 years-
Gain YTD3.5876.97851%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets401M106B0%
Annual Yield % from dividends1.041.5866%
Returns for 1 year4.089.8242%
Returns for 3 years19.6229.4367%
Returns for 5 years43.3463.5868%
Returns for 10 years58.6078.4175%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
URGN11.083.78
+51.78%
UroGen Pharma Ltd
TCRX1.610.01
+0.62%
TScan Therapeutics
MIDD143.88-2.83
-1.93%
Middleby Corp
RUM8.80-0.21
-2.33%
Rumble
NHPBP13.58-0.33
-2.37%
National Healthcare Properties Inc